Bottieau Emmanuel, Clerinx Jan, Schrooten Ward, Van den Enden Erwin, Wouters Raymond, Van Esbroeck Marjan, Vervoort Tony, Demey Hendrik, Colebunders Robert, Van Gompel Alfons, Van den Ende Jef
Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium.
Arch Intern Med. 2006;166(15):1642-8. doi: 10.1001/archinte.166.15.1642.
Information on epidemiology and prognosis of imported fever is scarce and almost exclusively limited to hospital settings.
From 2000 to 2005, all travelers presenting at our referral outpatient and inpatient centers with ongoing fever within 12 months after a stay in the tropics were prospectively followed. Case definitions and treatment were based on international recommendations. Outcome was assessed by at least 1 follow-up consultation or telephone call within 3 months after initial contact.
A total of 1842 fever episodes were included, involving 1743 patients. Regions of exposure were mainly sub-Saharan Africa (68%) and the Southeast Asia-Pacific region (12%). Tropical diseases accounted for 39% of all cases and cosmopolitan infections for 34%. Diagnosis often remained unknown (24%). The pattern of tropical diseases was mainly influenced by the travel destination, with malaria (35%, mainly Plasmodium falciparum) and rickettsial infection (4%) as the leading diagnoses after a stay in Africa; dengue (12%), malaria (9%), and enteric fever (4%) after travel to Asia; and dengue (8%) and malaria (4%) on return from Latin America. Disease pattern varied also according to the category of travelers, the delay between exposure and fever onset, and the setting. Hospitalization was required for 503 fever episodes (27%). Plasmodium falciparum malaria accounted for 36% of all admissions and was the only tropical cause of death (5 of 9 patients). Fever of unknown cause had invariably a favorable outcome.
The clinical spectrum of imported fever is highly destination specific but also depends on other factors. Plasmodium falciparum malaria was the leading cause of mortality in the study population.
关于输入性发热的流行病学和预后的信息稀缺,且几乎仅局限于医院环境。
2000年至2005年,对所有在热带地区停留12个月内出现持续发热并到我们的转诊门诊和住院中心就诊的旅行者进行前瞻性随访。病例定义和治疗基于国际推荐。在初次接触后3个月内,通过至少1次随访咨询或电话对结果进行评估。
共纳入1842例发热病例,涉及1743名患者。暴露地区主要是撒哈拉以南非洲(68%)和东南亚-太平洋地区(12%)。热带疾病占所有病例的39%,世界性感染占34%。诊断往往仍不明确(24%)。热带疾病的模式主要受旅行目的地影响,在非洲停留后,疟疾(35%,主要是恶性疟原虫)和立克次体感染(4%)是主要诊断;前往亚洲后,登革热(12%)、疟疾(9%)和伤寒(4%);从拉丁美洲返回后,登革热(8%)和疟疾(4%)。疾病模式也因旅行者类别、暴露与发热发作之间的间隔以及环境而异。503例发热病例(27%)需要住院治疗。恶性疟原虫疟疾占所有住院病例的36%,是唯一导致死亡的热带病因(9例患者中有5例)。不明原因发热的预后总是良好的。
输入性发热的临床谱具有高度的目的地特异性,但也取决于其他因素。在研究人群中,恶性疟原虫疟疾是主要的死亡原因。